The Debt-Funded Share Buyback You Can't Prove, and the Re-Geared Balance Sheet You Can
No filing lets you trace a euro from a bond issue to a repurchase contract, so the popular charge never sticks. What Birkenstock's filings do prove is a balance sheet re-geared on purpose, at a price you can calculate.
Strip the labels off Birkenstock's summer and the filings describe a simple sequence. In June its financing subsidiary priced €900 million of senior notes at a 4.500% coupon and put part of the proceeds towards redeeming €428.5 million of 5.25% notes due 2029. Alongside the refinancing, the company completed an accelerated share repurchase under a programme authorising up to $500 million; the repurchase cost €230 million in the accounts and retired roughly six million shares, per the third-quarter results filed with the SEC. Debt-funded share buybacks make for a tempting headline here. Resist it, because the charge is unprovable, and because it misses what the filings actually confess.
Money is fungible. Birkenstock generates real cash from selling sandals, and no disclosure lets you trace a particular euro from the bond issue into the repurchase contract. What the filings do prove is more deliberate and more interesting: the company raised roughly twice what it retired, shrank its equity in the same season, and let net leverage climb from 1.5x to 1.8x between September and June. That is not a buyback that happened to involve debt. It is a balance sheet re-geared on purpose, with the repurchase as one instrument among several. Capital allocation is a menu (build capacity, buy a competitor, raise the dividend, pay down debt, repurchase shares), and a board that re-gears while shrinking its equity has ranked that menu in public: its own stock, it is saying with money rather than adjectives, currently beats every other item. A claim that strong deserves interrogation rather than applause.
Why do companies borrow money to buy back shares?
Three reasons recur. The first is price: if debt costs 4.5% and management believes the equity is priced to return well above that, swapping one for the other works in shareholders' favour. The second is arithmetic: fewer shares spread over the same profit lift earnings per share even when the business has not improved, which flatters every per-share metric that bonuses and headlines are built on. The third is discipline avoidance, since a repurchase requires no integration plan and no forecast that can later be marked against you. From outside the boardroom the three look identical, so the useful work is pricing what the board actually did and then watching what it does next.
The price splits cleanly into parts (the arithmetic is ours, rounded). The refinancing leg saved money: moving €428.5 million from 5.25% to 4.500% trims about €3 million a year. The surplus is what costs. The other €470 million or so of the issue retired nothing, and its coupon adds roughly €21 million a year, which is why the net interest bill rises by about €18 million despite the cheaper rate. Around €230 million of that new capacity is matched by the shares already repurchased. The remaining €240 million or so sits as cash, and cash parked at short-term euro deposit rates earns nowhere near 4.500%: every percentage point of spread costs about €2.4 million a year, so the negative carry on the surplus runs to €5 million to €7 million annually on realistic deposit assumptions. None of these figures is large for a business of this profitability. All of them recur, and together they are the running price of the board's conviction that its own equity, plus optionality, beats everything else on the menu.
The beat that lives in the reconciliation table
Birkenstock's quarter shows why the distinction matters to anyone reading the accounts. Full-year guidance went up, with adjusted EBITDA now expected to reach at least €710 million. In the same statement, reported net profit fell 15% to €110 million while adjusted net profit rose 15% to €134 million, with €22 million of non-recurring, non-cash charges from the repurchase contract and the redemption of the old notes explaining most of the gap. Nobody lied. The argument simply moved from the income statement to the reconciliation table, where the two lines answer different questions and a reported decline coexists with an adjusted gain. A company running this much financing activity will keep generating exactly these one-off charges, so each quarter's beat will depend on readers agreeing to look through them; the width of the adjusted-versus-reported gap is the number worth tracking quarter by quarter.
Premium consumer brands importing into the United States carry an extra layer of pressure. Gross margin fell 140 basis points to 59.1%, and the company's own bridge spreads that decline across unfavourable currency translation, incremental US tariffs and a 20 basis point mark-up effect from absorbing the inventory of its Australian distributor, a purchase that closed in October 2025. That last item is small, but the strategy behind it isn't: buying out third-party distributors to sell direct front-loads acquisition costs, inventory and lease commitments in exchange for owning the customer relationship, so reported earnings will keep trailing the underlying machine for a while yet. Strong demand disguises margin compression without removing it, and quoting growth in constant currency is honest about operations while staying silent about what shareholders actually receive. Re-gearing the balance sheet in that setting is management's way of saying it believes the machine.
Are debt-funded share buybacks good capital allocation?
Sometimes, under conditions Birkenstock mostly meets: stable cash generation, cheap fixed-rate debt, leverage that stays modest even after the increase. The case weakens when demand is cyclical, margins are quietly compressing and the repurchase's main output is per-share optics, and this company has at least the second symptom. History supplies a caution the arithmetic cannot: corporate enthusiasm for repurchases has tended to peak alongside share prices, which is the wrong shape for a value strategy.
The settling evidence can be named in advance, and the surplus cash is the tell. If the parked money flows into further repurchases under the $500 million authorisation while the adjusted-versus-reported gap keeps widening, the re-gearing will have been financial engineering: debt manufacturing per-share growth that operations were failing to supply. If it funds more distributor buyouts while gross margins stabilise, free cash flow covers the enlarged interest bill and reported profit closes on adjusted, then the board built a war chest for an operating strategy and treated the carry as the cost of being able to move quickly. Neither verdict is available today, which is exactly why the discipline is choosing the evidence now and then waiting for it.
The asymmetry deserves a line in any verdict. If management is right about its equity, shareholders collect a modest, levered improvement they could have approximated elsewhere. If it is wrong, the costs arrive together, because the conditions that make a repurchase look mistimed (softer demand, thinner margins) are the same conditions in which a larger interest bill and reduced flexibility bite hardest. Capped, diversifiable upside against correlated downside is a trade worth recognising before you underwrite it.
The transferable lesson has nothing to do with sandals. Boards allocating technology capital face the same menu and routinely skip the pricing step, most visibly with AI, where the named platform programme gets funded while the boring option, fixing the data any model would depend on, never gets costed. RAND's interviews with machine-learning practitioners place inadequate or low-quality data among the leading root causes of failed AI projects, which suggests the dull item on the menu often carries the higher return, much as Birkenstock's dullest move, swapping 5.25% paper for cheaper money, was its most defensible one. The test travels intact: list the menu, price every item including the boring ones, and name the settling evidence before the money moves. That is the case for proving readiness before you build, and for a technical strategy that starts with the pricing rather than the platform.
Questions people ask
How do share buybacks increase earnings per share?
A buyback reduces the number of shares in issue, so the same net profit is divided among fewer shares and earnings per share rises. Total profit is unchanged; each remaining share simply owns a larger slice of it. The check is to compare growth in total net profit with growth in EPS: a wide gap means the improvement is coming from the share count rather than the business.
Does a buyback funded by debt mean the stock is undervalued?
It means management believes it is, which is evidence but not proof. Boards have an incentive to support per-share metrics and a mixed record of timing their own purchases. Stronger corroboration includes directors buying with personal money, a valuation below the company's own history, and reported profit keeping pace with adjusted profit after the repurchase.
How does a share buyback affect a company's leverage?
Cash or new borrowing goes out and equity shrinks, so debt relative to earnings and to equity both rise. Funded from surplus cash the effect is mild; funded with new bonds it is a deliberate re-gearing of the balance sheet. The practical questions are whether fixed-rate interest is comfortably covered by free cash flow and how much headroom remains if demand softens.
Related
- Your Cloud Provider Is Financing Its Own AI Revenue. Do the Financial Due Diligence
- The Announcement Is Not the Deal: AI Infrastructure's Announced vs Contracted Gap
- The Rule of 70: Why an Age-Plus-Tenure Redundancy Selection Formula Still Has to Justify Itself
- Data & Strategy
Written by an AI editorial persona of Abyshire's proprietary editorial system and reviewed by our team.